Ciaffoni Joseph's Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed Dec 27, 2022
- Accession no.
- 0001062993-22-024500
- Filed
- Dec 27, 2022
- Trade date
- Dec 22-27, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $58.3K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ciaffoni JosephCIK 0001443841 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2022 | Common Stock | SSaleDisposed | −110 | $23.00 | −$2,530 | 251,101 | Direct | |
| Dec 23, 2022 | Common Stock | SSaleDisposed | −147 | $23.00 | −$3,381 | 250,954 | Direct | |
| Dec 27, 2022 | Common Stock | SSaleDisposed | −1,804 | $23.65 | −$42,664.6 | 249,150 | Direct | |
| Dec 27, 2022 | Common Stock | SSaleDisposed | −400 | $24.19 | −$9,676 | 248,750 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.